-
1621
The Global Burden of Emerging and Re-Emerging Orbiviruses in Livestock: An Emphasis on Bluetongue Virus and Epizootic Hemorrhagic Disease Virus
Published 2024-12-01Subjects: Get full text
Article -
1622
What was Killing Babies in Ipswich Between 1872 and 1909?
Published 2022-07-01Subjects: Get full text
Article -
1623
Foreword: Prevention of COVID-19, Influenza, and Respiratory Syncytial Virus in At-Risk Populations
Published 2024-12-01Subjects: Get full text
Article -
1624
Impact of interventions on mpox transmission during the 2022 outbreak in Canada: a mathematical modeling study of three different cities
Published 2025-04-01Subjects: Get full text
Article -
1625
The safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) in combination with rabies vaccination in Chinese healthy adults: A phase Ib randomized, double-blind, parallel-controlled clinical study
Published 2025-01-01“…This study compared the safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) and HRIG in combination with rabies vaccine and vaccine alone. Method: This randomized, double-blind, parallel-controlled Phase Ib clinical study was conducted in healthy Chinese population to evaluate the safety, pharmacokinetics, and neutralizing activity of rhRIG at dosages of 20IU/kg and 40IU/kg in combination with vaccines, and to compare the neutralizing activity of rhRIG + vaccine with that of HRIG + vaccine and vaccine alone. 72 healthy participants divided into 6 groups of 12 individuals. …”
Get full text
Article -
1626
Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers – the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol
Published 2022-06-01“…Individuals complete enrolment and fortnightly questionnaires on exposures, symptoms and vaccination. Follow-up is 12 months from study entry, with an option to extend follow-up to 24 months.The primary outcome of interest is infection with SARS-CoV-2 after previous SARS-CoV-2 infection or COVID-19 vaccination during the study period. …”
Get full text
Article -
1627
The development and maintenance of immunity against visceral leishmaniasis
Published 2024-12-01Subjects: Get full text
Article -
1628
Highly pathogenic bovine viral diarrhea virus BJ-11 unveils genetic evolution related to virulence in calves
Published 2025-01-01Subjects: Get full text
Article -
1629
Mathematical analysis of COVID-19 dynamics in Iraq utilising empirical data
Published 2025-03-01Subjects: Get full text
Article -
1630
Mathematical Modeling of Tuberculosis Transmission Dynamics With Reinfection and Optimal Control
Published 2025-01-01Subjects: Get full text
Article -
1631
Swine Acute Diarrhea Syndrome Coronavirus: An Overview of Virus Structure and Virus–Host Interactions
Published 2025-01-01Subjects: Get full text
Article -
1632
Mathematical modeling and simulation of hepatitis B transmission dynamics with passive immunity and control strategies
Published 2025-01-01Subjects: Get full text
Article -
1633
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
Published 2021Subjects: “…COVID-19 therapy; COVID-19 vaccine; COVID-19 convalescent therapy; SARS-CoV-2 infection; human antibodies; variants of concern; Ebola…”
Get full text
Article -
1634
Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial)
Published 2022-06-01“…In the Rotterdam PancrEAtic Cancer Vaccination-2 trial, we aim to translate our findings into patients. …”
Get full text
Article -
1635
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
Published 2023Subjects: Get full text
Article -
1636
Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection
Published 2025-01-01Subjects: Get full text
Article -
1637
The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
Published 2025-12-01Subjects: Get full text
Article -
1638
A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice
Published 2018-01-01“…The results implied development of low-cost E. coli-derived DT: 11-88 peptide formulated in human compatible ISA 720 adjuvant as a HPV vaccine.…”
Get full text
Article -
1639
Vector‐Free Deep Tissue Targeting of DNA/RNA Therapeutics via Single Capacitive Discharge Conductivity‐Clamped Gene Electrotransfer
Published 2025-01-01Subjects: “…DNA and RNA vaccines…”
Get full text
Article -
1640
UNICEF ÇOCUK REFAHI SAĞLIK GÖSTERGELERİNE GÖRE OECD ÜLKELERİNİN KARŞILAŞTIRILMASI
Published 2023-05-01Subjects: “…vaccination…”
Get full text
Article